Integer Holdings Corporation (NYSE:ITGR) Given Consensus Rating of "Buy" by Brokerages

Integer Holdings Corporation (NYSE:ITGR - Get Free Report) has received an average rating of "Buy" from the nine brokerages that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $146.25.

A number of equities research analysts have issued reports on the company. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Raymond James Financial increased their price objective on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, April 25th. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a report on Friday, April 25th. Finally, Benchmark dropped their price objective on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th.

Integer Stock Down 2.6%

ITGR traded down $3.04 on Tuesday, hitting $111.60. The company had a trading volume of 162,953 shares, compared to its average volume of 487,327. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. The stock has a market capitalization of $3.89 billion, a price-to-earnings ratio of 52.86, a P/E/G ratio of 1.01 and a beta of 0.98. The stock has a fifty day moving average price of $119.76 and a 200-day moving average price of $124.59. Integer has a 12-month low of $104.93 and a 12-month high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Integer had a return on equity of 11.95% and a net margin of 4.38%. The firm had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the previous year, the company posted $1.14 earnings per share. The company's revenue was up 7.3% compared to the same quarter last year. Analysts predict that Integer will post 6.01 EPS for the current fiscal year.

Insider Buying and Selling

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the transaction, the director owned 18,781 shares in the company, valued at $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock worth $44,577,115 in the last quarter. 2.16% of the stock is owned by insiders.

Institutional Trading of Integer

Hedge funds have recently modified their holdings of the business. Lee Danner & Bass Inc. acquired a new stake in shares of Integer in the 4th quarter valued at approximately $27,000. Opal Wealth Advisors LLC acquired a new stake in shares of Integer in the 1st quarter valued at approximately $28,000. AdvisorNet Financial Inc acquired a new stake in shares of Integer in the 1st quarter valued at approximately $28,000. SVB Wealth LLC acquired a new stake in shares of Integer in the 1st quarter valued at approximately $35,000. Finally, Bessemer Group Inc. lifted its holdings in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 125 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.